Dekabank Deutsche Girozentrale Increased Its Stake in Pfizer INC (PFE) by $36.55 Million as Shares Declined

June 26, 2018 - By Daniel Cummings

Pfizer Inc. (NYSE:PFE) Corporate LogoBig Money Sentiment decreased to 0.89 in Q1 2018. It has change of 0.17, from 2017Q4’s 1.06. The ratio dived due to PFE positioning: 70 sold and 718 reduced. 104 funds took stakes and 595 increased stakes. Investors holded 4.07 billion in 2017Q4 but now own 4.01 billion shares or 1.39% less. Grantham Mayo Van Otterloo And Ltd reported 0.93% of its capital in Pfizer Inc. (NYSE:PFE). Crawford Investment Counsel holds 0.51% in Pfizer Inc. (NYSE:PFE) or 452,489 shs. The Nebraska-based Lincoln Capital Limited Liability Corp has invested 0.22% in Pfizer Inc. (NYSE:PFE). Loomis Sayles And Co LP stated it has 623,926 shs. Tocqueville Asset Management Limited Partnership has 1.58M shs for 0.71% of their capital. Marshwinds Advisory reported 123,263 shs or 2.08% of all its holdings. Estabrook has invested 0% in Pfizer Inc. (NYSE:PFE). Fiduciary Trust Company holds 0.61% or 555,624 shs. Carlson Mngmt reported 8,661 shs stake. 229,869 were accumulated by Northpointe Cap Llc. Patten Grp holds 0.07% or 4,846 shs in its capital. Kentucky Retirement accumulated 310,669 shs. Sumitomo Mitsui Trust holds 0.86% or 18.88M shs in its capital. First Trust reported 0.54% of its capital in Pfizer Inc. (NYSE:PFE). Forbes J M And Ltd Liability Partnership holds 2.66% or 321,762 shs.

PFE registered $18.09 million net activity with 0 buys and 13 selling transactions since February 24, 2018. On Monday, February 26 $1.24 million worth of Pfizer Inc. (NYSE:PFE) was sold by SUSMAN SALLY. LUND-JURGENSEN KIRSTEN sold $353,677 worth of stock or 9,510 shs. On Friday, March 9 Dolsten Mikael sold $2.55 million worth of Pfizer Inc. (NYSE:PFE). 27,323 Pfizer Inc. (NYSE:PFE) shs with value of $998,666 were sold by JOHNSON RADY A. $692,582 worth of Pfizer Inc. (NYSE:PFE) was sold by OLSON LAURIE J on Wednesday, June 6. CORNWELL W DON sold $64,679 worth of Pfizer Inc. (NYSE:PFE) or 1,758 shs on Monday, February 26.

Dekabank Deutsche Girozentrale upped its stake by 21.65% in Pfizer Inc (PFE), according to 2018Q1 Securities and Exchange filling. The company’s stock declined 3.80% with the market as Dekabank Deutsche Girozentrale bought 1.04M shares. At the end of 2018Q1, the institutional investor held 5.87 million shares of the health care company, priced at $208.07 million, up from 4.82M at the end of the previous reported quarter. $213.71B is Pfizer Inc’s MC. Ticker’s shares touched $36.535 during the last trading session after 0.43% change.Currently Pfizer Inc. is uptrending after 10.95% change in last June 26, 2017. PFE has 2.30 million shares volume. PFE underperformed by 1.62% the S&P500.

The Dekabank Deutsche Girozentrale’s stake in Ashland Global Hldgs Inc was reduced by 188,261 shares to 395,545 shares valued at $27.32 million in 2018Q1, according to the filing. It manages about $14.62B US Long portfolio. For a total of 46,839 shares it reduced its holding in Edwards Lifesciences Corp (NYSE:EW) by 116,511 shares in the quarter, and has cut its stake in Equity Residential (NYSE:EQR).

For more Pfizer Inc. (NYSE:PFE) news published briefly go to: Fool.com, Fool.com, Seekingalpha.com, Fool.com or Seekingalpha.com. The titles are as follows: “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks” published on June 20, 2018, “If You’re in Your 70s, Consider Buying These 3 Stocks” on June 26, 2018, “Pfizer – Still A Hold For The Dividend” with a publish date: June 08, 2018, “Better Buy: Pfizer Inc. vs. Johnson & Johnson” and the last “3 Things In Biotech, June 26: One Piece Of Good News Offset By A Cascade Of Bad?” with publication date: June 26, 2018.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

In total 10 analysts cover Pfizer (NYSE:PFE). “Buy” rating has 4, “Sell” are 1, while 5 are “Hold”. 40% are bullish. With $4500 highest and $3800 lowest PT Pfizer has $40.67 average PT or 11.32% above the current ($36.535) price. 13 are the (NYSE:PFE)’s analyst reports since January 16, 2018 according to StockzIntelligence Inc. The company rating was maintained by Credit Suisse on Wednesday, January 31. On Friday, April 13 the stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given by Jefferies. On Wednesday, May 2 BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) rating. BMO Capital Markets has “Outperform” rating and $42 target. On Tuesday, January 16 Jefferies maintained the shares of PFE in report with “Hold” rating. On Thursday, April 5 Barclays Capital downgraded the shares of PFE in report to “Equal-Weight” rating. The company rating was maintained by Jefferies on Monday, February 26. In Thursday, June 7 report Cantor Fitzgerald initiated the stock with “Buy” rating. On Sunday, January 28 SunTrust maintained Pfizer Inc. (NYSE:PFE) with “Hold” rating. In Wednesday, January 31 report Leerink Swann maintained the stock with “Market Perform” rating. In Wednesday, January 31 report Morgan Stanley maintained the stock with “Overweight” rating.

Pfizer Inc. (NYSE:PFE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.